| Product Code: ETC7761424 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Hereditary Angioedema Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Hereditary Angioedema Market - Industry Life Cycle |
3.4 Jordan Hereditary Angioedema Market - Porter's Five Forces |
3.5 Jordan Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Jordan Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Jordan Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Jordan Hereditary Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about hereditary angioedema (HAE) in Jordan |
4.2.2 Growing research and development activities focused on HAE treatments |
4.2.3 Rising prevalence of HAE cases in Jordan |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for HAE diagnosis and treatment in Jordan |
4.3.2 High cost associated with HAE medications and treatments |
4.3.3 Lack of standardized protocols for HAE management in Jordan |
5 Jordan Hereditary Angioedema Market Trends |
6 Jordan Hereditary Angioedema Market, By Types |
6.1 Jordan Hereditary Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Jordan Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Jordan Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F |
6.1.4 Jordan Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.1.5 Jordan Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.6 Jordan Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Jordan Hereditary Angioedema Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Jordan Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.3 Jordan Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F |
6.2.4 Jordan Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.3 Jordan Hereditary Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Jordan Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Jordan Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Jordan Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 Jordan Hereditary Angioedema Market Import-Export Trade Statistics |
7.1 Jordan Hereditary Angioedema Market Export to Major Countries |
7.2 Jordan Hereditary Angioedema Market Imports from Major Countries |
8 Jordan Hereditary Angioedema Market Key Performance Indicators |
8.1 Number of HAE awareness campaigns conducted in Jordan |
8.2 Percentage increase in HAE research funding in Jordan |
8.3 Number of HAE patients diagnosed and treated in Jordan |
8.4 Average time taken for HAE diagnosis and initiation of treatment |
8.5 Percentage of healthcare professionals trained in HAE management in Jordan |
9 Jordan Hereditary Angioedema Market - Opportunity Assessment |
9.1 Jordan Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Jordan Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Jordan Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Jordan Hereditary Angioedema Market - Competitive Landscape |
10.1 Jordan Hereditary Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Jordan Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here